SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Nektar Therapeutics Schedules Third-Quarter Results Release

Nektar Therapeutics scheduled the release of its third-quarter results.

NKTR

Related stories